Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1035 entries
Sorted by: Best Match Show Resources per page
[Educational lecture of diabetes mellitus (author's transl)].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

Hirata Y.
PMID: 731108
Nihon Naika Gakkai Zasshi. 1978 Nov 10;67(11):1378-83. doi: 10.2169/naika.67.1378.

No abstract available.

Cite
Hirata Y. [Educational lecture of diabetes mellitus (author's transl)]. Nihon Naika Gakkai Zasshi. 1978;67(11):1378-83doi: 10.2169/naika.67.1378.
Hirata, Y. (1978). [Educational lecture of diabetes mellitus (author's transl)]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 67(11), 1378-83. https://doi.org/10.2169/naika.67.1378
Hirata, Y. "[Educational lecture of diabetes mellitus (author's transl)]." Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine vol. 67,11 (1978): 1378-83. doi: https://doi.org/10.2169/naika.67.1378
Hirata Y. [Educational lecture of diabetes mellitus (author's transl)]. Nihon Naika Gakkai Zasshi. 1978 Nov 10;67(11):1378-83. doi: 10.2169/naika.67.1378. Japanese. PMID: 731108.
Copy Download .nbib Format: NLM
Pressure-Induced Mott Transition Followed by a 24-K Superconducting Phase in BaFe_{2}S_{3}.

Physical review letters

Yamauchi T, Hirata Y, Ueda Y, Ohgushi K.
PMID: 26705643
Phys Rev Lett. 2015 Dec 11;115(24):246402. doi: 10.1103/PhysRevLett.115.246402. Epub 2015 Dec 08.

We performed high-pressure study for a Mott insulator BaFe_{2}S_{3}, by measuring dc resistivity and ac susceptibility up to 15 GPa. We found that the antiferromagnetic insulating state at the ambient pressure is transformed into a metallic state at the...

Cite
Yamauchi T, Hirata Y, Ueda Y, et al. Pressure-Induced Mott Transition Followed by a 24-K Superconducting Phase in BaFe_{2}S_{3}. Phys Rev Lett. 2015;115(24):246402doi: 10.1103/PhysRevLett.115.246402.
Yamauchi, T., Hirata, Y., Ueda, Y., & Ohgushi, K. (2015). Pressure-Induced Mott Transition Followed by a 24-K Superconducting Phase in BaFe_{2}S_{3}. Physical review letters, 115(24), 246402. https://doi.org/10.1103/PhysRevLett.115.246402
Yamauchi, Touru, et al. "Pressure-Induced Mott Transition Followed by a 24-K Superconducting Phase in BaFe_{2}S_{3}." Physical review letters vol. 115,24 (2015): 246402. doi: https://doi.org/10.1103/PhysRevLett.115.246402
Yamauchi T, Hirata Y, Ueda Y, Ohgushi K. Pressure-Induced Mott Transition Followed by a 24-K Superconducting Phase in BaFe_{2}S_{3}. Phys Rev Lett. 2015 Dec 11;115(24):246402. doi: 10.1103/PhysRevLett.115.246402. Epub 2015 Dec 08. PMID: 26705643.
Copy Download .nbib Format: NLM
Acute diffuse peritonitis due to spontaneous rupture of a primary gastrointestinal stromal tumor of the jejunum: A case report.

International journal of surgery case reports

Sato K, Tazawa H, Fujisaki S, Fukuhara S, Imaoka K, Hirata Y, Takahashi M, Fukuda S, Kuga Y, Nishida T, Sakimoto H.
PMID: 28888914
Int J Surg Case Rep. 2017;39:288-292. doi: 10.1016/j.ijscr.2017.08.041. Epub 2017 Aug 23.

INTRODUCTION: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. Overt peritonitis caused by GIST rupture is very uncommon. Three types of GIST rupture have been described: closed perforation due to abscess (abscess type),...

Cite
Sato K, Tazawa H, Fujisaki S, et al. Acute diffuse peritonitis due to spontaneous rupture of a primary gastrointestinal stromal tumor of the jejunum: A case report. Int J Surg Case Rep. 2017;39:288-292doi: 10.1016/j.ijscr.2017.08.041.
Sato, K., Tazawa, H., Fujisaki, S., Fukuhara, S., Imaoka, K., Hirata, Y., Takahashi, M., Fukuda, S., Kuga, Y., Nishida, T., & Sakimoto, H. (2017). Acute diffuse peritonitis due to spontaneous rupture of a primary gastrointestinal stromal tumor of the jejunum: A case report. International journal of surgery case reports, 39288-292. https://doi.org/10.1016/j.ijscr.2017.08.041
Sato, Koki, et al. "Acute diffuse peritonitis due to spontaneous rupture of a primary gastrointestinal stromal tumor of the jejunum: A case report." International journal of surgery case reports vol. 39 (2017): 288-292. doi: https://doi.org/10.1016/j.ijscr.2017.08.041
Sato K, Tazawa H, Fujisaki S, Fukuhara S, Imaoka K, Hirata Y, Takahashi M, Fukuda S, Kuga Y, Nishida T, Sakimoto H. Acute diffuse peritonitis due to spontaneous rupture of a primary gastrointestinal stromal tumor of the jejunum: A case report. Int J Surg Case Rep. 2017;39:288-292. doi: 10.1016/j.ijscr.2017.08.041. Epub 2017 Aug 23. PMID: 28888914; PMCID: PMC5596258.
Copy Download .nbib Format: NLM
A highly active and stable IrOx/SrIrO3 catalyst for the oxygen evolution reaction.

Science (New York, N.Y.)

Seitz LC, Dickens CF, Nishio K, Hikita Y, Montoya J, Doyle A, Kirk C, Vojvodic A, Hwang HY, Norskov JK, Jaramillo TF.
PMID: 27701108
Science. 2016 Sep 02;353(6303):1011-1014. doi: 10.1126/science.aaf5050.

Oxygen electrochemistry plays a key role in renewable energy technologies such as fuel cells and electrolyzers, but the slow kinetics of the oxygen evolution reaction (OER) limit the performance and commercialization of such devices. Here we report an iridium...

Cite
Seitz LC, Dickens CF, Nishio K, et al. A highly active and stable IrOx/SrIrO3 catalyst for the oxygen evolution reaction. Science. 2016;353(6303):1011-1014doi: 10.1126/science.aaf5050.
Seitz, L. C., Dickens, C. F., Nishio, K., Hikita, Y., Montoya, J., Doyle, A., Kirk, C., Vojvodic, A., Hwang, H. Y., Norskov, J. K., & Jaramillo, T. F. (2016). A highly active and stable IrOx/SrIrO3 catalyst for the oxygen evolution reaction. Science (New York, N.Y.), 353(6303), 1011-1014. https://doi.org/10.1126/science.aaf5050
Seitz, Linsey C, et al. "A highly active and stable IrOx/SrIrO3 catalyst for the oxygen evolution reaction." Science (New York, N.Y.) vol. 353,6303 (2016): 1011-1014. doi: https://doi.org/10.1126/science.aaf5050
Seitz LC, Dickens CF, Nishio K, Hikita Y, Montoya J, Doyle A, Kirk C, Vojvodic A, Hwang HY, Norskov JK, Jaramillo TF. A highly active and stable IrOx/SrIrO3 catalyst for the oxygen evolution reaction. Science. 2016 Sep 02;353(6303):1011-1014. doi: 10.1126/science.aaf5050. PMID: 27701108.
Copy Download .nbib Format: NLM
OFF-ON-OFF fluorescent response of N,N,N',N'-tetrakis(1-isoquinolylmethyl)-2-hydroxy-1,3-propanediamine (1-isoHTQHPN) toward Zn(2.).

Dalton transactions (Cambridge, England : 2003)

Mikata Y, Ohnishi R, Ugai A, Konno H, Nakata Y, Hamagami I, Sato S.
PMID: 27007647
Dalton Trans. 2016 Apr 25;45(17):7250-7. doi: 10.1039/c6dt00506c.

An isoquinoline-based ligand, N,N,N',N'-tetrakis(1-isoquinolylmethyl)-2-hydroxy-1,3-propanediamine (1-isoHTQHPN), exhibits a fluorescence increase at 475 nm upon addition of 1 equiv. of Zn(2+) (IZn/I0 = 12, ϕZn = 0.023). This fluorescence enhancement turns and then decreases sharply after the addition of more than...

Cite
Mikata Y, Ohnishi R, Ugai A, et al. OFF-ON-OFF fluorescent response of N,N,N',N'-tetrakis(1-isoquinolylmethyl)-2-hydroxy-1,3-propanediamine (1-isoHTQHPN) toward Zn(2.). Dalton Trans. 2016;45(17):7250-7doi: 10.1039/c6dt00506c.
Mikata, Y., Ohnishi, R., Ugai, A., Konno, H., Nakata, Y., Hamagami, I., & Sato, S. (2016). OFF-ON-OFF fluorescent response of N,N,N',N'-tetrakis(1-isoquinolylmethyl)-2-hydroxy-1,3-propanediamine (1-isoHTQHPN) toward Zn(2.). Dalton transactions (Cambridge, England : 2003), 45(17), 7250-7. https://doi.org/10.1039/c6dt00506c
Mikata, Yuji, et al. "OFF-ON-OFF fluorescent response of N,N,N',N'-tetrakis(1-isoquinolylmethyl)-2-hydroxy-1,3-propanediamine (1-isoHTQHPN) toward Zn(2.)." Dalton transactions (Cambridge, England : 2003) vol. 45,17 (2016): 7250-7. doi: https://doi.org/10.1039/c6dt00506c
Mikata Y, Ohnishi R, Ugai A, Konno H, Nakata Y, Hamagami I, Sato S. OFF-ON-OFF fluorescent response of N,N,N',N'-tetrakis(1-isoquinolylmethyl)-2-hydroxy-1,3-propanediamine (1-isoHTQHPN) toward Zn(2.). Dalton Trans. 2016 Apr 25;45(17):7250-7. doi: 10.1039/c6dt00506c. PMID: 27007647.
Copy Download .nbib Format: NLM
Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer.

Oncology letters

Miyata Y, Mitsunari K, Akihiro A, Watanabe SI, Matsuo T, Ohba K, Sakai H.
PMID: 28356963
Oncol Lett. 2017 Feb;13(2):811-818. doi: 10.3892/ol.2016.5484. Epub 2016 Dec 12.

In patients with advanced urothelial cancer (UC), a combination of cisplatin (CDDP) and gemcitabine (GEM) is the most commonly used first-line systematic chemotherapy regimen. Although no standard regime for the treatment of CDDP-resistant UC has been established, GEM-based regimens...

Cite
Miyata Y, Mitsunari K, Akihiro A, et al. Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer. Oncol Lett. 2016;13(2):811-818doi: 10.3892/ol.2016.5484.
Miyata, Y., Mitsunari, K., Akihiro, A., Watanabe, S. I., Matsuo, T., Ohba, K., & Sakai, H. (2017). Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer. Oncology letters, 13(2), 811-818. https://doi.org/10.3892/ol.2016.5484
Miyata, Yasuyoshi, et al. "Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer." Oncology letters vol. 13,2 (2017): 811-818. doi: https://doi.org/10.3892/ol.2016.5484
Miyata Y, Mitsunari K, Akihiro A, Watanabe SI, Matsuo T, Ohba K, Sakai H. Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer. Oncol Lett. 2017 Feb;13(2):811-818. doi: 10.3892/ol.2016.5484. Epub 2016 Dec 12. PMID: 28356963; PMCID: PMC5351343.
Copy Download .nbib Format: NLM
Diagnostic utility of cardiac magnetic resonance for detection of cardiac involvement in female carriers of Duchenne muscular dystrophy.

Heart Asia

Iwase T, Takao S, Akaike M, Adachi K, Sumitomo-Ueda Y, Yagi S, Niki T, Kusunose K, Tomita N, Hirata Y, Yamaguchi K, Koshiba K, Taketani Y, Yamada H, Soeki T, Wakatsuki T, Aihara K, Harada M, Nishitani H, Sata M.
PMID: 27325943
Heart Asia. 2010 Jul 29;2(1):52-5. doi: 10.1136/ha.2010.002006. eCollection 2010.

BACKGROUND: Cardiac involvement is a recognised complication in female carriers of Duchenne muscular dystrophy (DMD). Since segmental or global left ventricle (LV) wall motion abnormalities in DMD carriers can arise even without apparent muscle weakness, it is difficult to...

Cite
Iwase T, Takao S, Akaike M, et al. Diagnostic utility of cardiac magnetic resonance for detection of cardiac involvement in female carriers of Duchenne muscular dystrophy. Heart Asia. 2010;2(1):52-5doi: 10.1136/ha.2010.002006.
Iwase, T., Takao, S., Akaike, M., Adachi, K., Sumitomo-Ueda, Y., Yagi, S., Niki, T., Kusunose, K., Tomita, N., Hirata, Y., Yamaguchi, K., Koshiba, K., Taketani, Y., Yamada, H., Soeki, T., Wakatsuki, T., Aihara, K., Harada, M., Nishitani, H., & Sata, M. (2010). Diagnostic utility of cardiac magnetic resonance for detection of cardiac involvement in female carriers of Duchenne muscular dystrophy. Heart Asia, 2(1), 52-5. https://doi.org/10.1136/ha.2010.002006
Iwase, Takashi, et al. "Diagnostic utility of cardiac magnetic resonance for detection of cardiac involvement in female carriers of Duchenne muscular dystrophy." Heart Asia vol. 2,1 (2010): 52-5. doi: https://doi.org/10.1136/ha.2010.002006
Iwase T, Takao S, Akaike M, Adachi K, Sumitomo-Ueda Y, Yagi S, Niki T, Kusunose K, Tomita N, Hirata Y, Yamaguchi K, Koshiba K, Taketani Y, Yamada H, Soeki T, Wakatsuki T, Aihara K, Harada M, Nishitani H, Sata M. Diagnostic utility of cardiac magnetic resonance for detection of cardiac involvement in female carriers of Duchenne muscular dystrophy. Heart Asia. 2010 Jul 29;2(1):52-5. doi: 10.1136/ha.2010.002006. eCollection 2010. PMID: 27325943; PMCID: PMC4898527.
Copy Download .nbib Format: NLM
Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues.

Bioscience, biotechnology, and biochemistry

Toshima H, Nara S, Ichihara A, Koda Y, Kikuta Y.
PMID: 27392555
Biosci Biotechnol Biochem. 1998;62(4):681-8. doi: 10.1271/bbb.62.681.

Coronafacic acid (1) is an acid component of coronatine, and has been isolated from several pathovars of Pseudomonas syringae. Syntheses of C6-non- and C6-alkyl-substituted analogues of 1 were accomplished via intramolecular 1,6-conjugate addition as the key step. Among them,...

Cite
Toshima H, Nara S, Ichihara A, et al. Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues. Biosci Biotechnol Biochem. 1998;62(4):681-8doi: 10.1271/bbb.62.681.
Toshima, H., Nara, S., Ichihara, A., Koda, Y., & Kikuta, Y. (1998). Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues. Bioscience, biotechnology, and biochemistry, 62(4), 681-8. https://doi.org/10.1271/bbb.62.681
Toshima, H, et al. "Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues." Bioscience, biotechnology, and biochemistry vol. 62,4 (1998): 681-8. doi: https://doi.org/10.1271/bbb.62.681
Toshima H, Nara S, Ichihara A, Koda Y, Kikuta Y. Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues. Biosci Biotechnol Biochem. 1998;62(4):681-8. doi: 10.1271/bbb.62.681. PMID: 27392555.
Copy Download .nbib Format: NLM
Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis.

Hepatology research : the official journal of the Japan Society of Hepatology

Naeshiro N, Aikata H, Hyogo H, Kan H, Fujino H, Kobayashi T, Fukuhara T, Honda Y, Nakahara T, Ohno A, Miyaki D, Murakami E, Kawaoka T, Tsuge M, Hiraga N, Hiramatsu A, Imamura M, Kawakami Y, Ochi H, Chayama K.
PMID: 25088236
Hepatol Res. 2015 Jun;45(6):656-62. doi: 10.1111/hepr.12400. Epub 2014 Sep 02.

AIM: To assess the efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis (PVT) in patients with liver cirrhosis.METHODS: A consecutive 26 cirrhotic patients with PVT were enrolled in this retrospective cohort...

Cite
Naeshiro N, Aikata H, Hyogo H, et al. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatol Res. 2014;45(6):656-62doi: 10.1111/hepr.12400.
Naeshiro, N., Aikata, H., Hyogo, H., Kan, H., Fujino, H., Kobayashi, T., Fukuhara, T., Honda, Y., Nakahara, T., Ohno, A., Miyaki, D., Murakami, E., Kawaoka, T., Tsuge, M., Hiraga, N., Hiramatsu, A., Imamura, M., Kawakami, Y., Ochi, H., & Chayama, K. (2015). Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatology research : the official journal of the Japan Society of Hepatology, 45(6), 656-62. https://doi.org/10.1111/hepr.12400
Naeshiro, Noriaki, et al. "Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis." Hepatology research : the official journal of the Japan Society of Hepatology vol. 45,6 (2015): 656-62. doi: https://doi.org/10.1111/hepr.12400
Naeshiro N, Aikata H, Hyogo H, Kan H, Fujino H, Kobayashi T, Fukuhara T, Honda Y, Nakahara T, Ohno A, Miyaki D, Murakami E, Kawaoka T, Tsuge M, Hiraga N, Hiramatsu A, Imamura M, Kawakami Y, Ochi H, Chayama K. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatol Res. 2015 Jun;45(6):656-62. doi: 10.1111/hepr.12400. Epub 2014 Sep 02. PMID: 25088236.
Copy Download .nbib Format: NLM
Response.

Gastrointestinal endoscopy

Hirata Y, Shichijo S, Koike K.
PMID: 27424194
Gastrointest Endosc. 2016 Nov;84(5):876-877. doi: 10.1016/j.gie.2016.07.004. Epub 2016 Jul 15.

No abstract available.

Cite
Hirata Y, Shichijo S, Koike K. Response. Gastrointest Endosc. 2016;84(5):876-877doi: 10.1016/j.gie.2016.07.004.
Hirata, Y., Shichijo, S., & Koike, K. (2016). Response. Gastrointestinal endoscopy, 84(5), 876-877. https://doi.org/10.1016/j.gie.2016.07.004
Hirata, Yoshihiro, et al. "Response." Gastrointestinal endoscopy vol. 84,5 (2016): 876-877. doi: https://doi.org/10.1016/j.gie.2016.07.004
Hirata Y, Shichijo S, Koike K. Response. Gastrointest Endosc. 2016 Nov;84(5):876-877. doi: 10.1016/j.gie.2016.07.004. Epub 2016 Jul 15. PMID: 27424194.
Copy Download .nbib Format: NLM
Histomorphometric analysis of minimodeling in the vertebrae in postmenopausal patients treated with anti-osteoporotic agents.

Bone reports

Hikata T, Hasegawa T, Horiuchi K, Fujita N, Iwanami A, Watanabe K, Ishii K, Nakamura M, Amizuka N, Matsumoto M.
PMID: 28580398
Bone Rep. 2016 Oct 13;5:286-291. doi: 10.1016/j.bonr.2016.10.002. eCollection 2016 Dec.

Minimodeling is a type of focal bone formation that is characterized by the lack of precedent bone erosion by osteoclasts. Although this form of bone formation has been described for more than a decade, how anti-osteoporotic agents that are...

Cite
Hikata T, Hasegawa T, Horiuchi K, et al. Histomorphometric analysis of minimodeling in the vertebrae in postmenopausal patients treated with anti-osteoporotic agents. Bone Rep. 2016;5:286-291doi: 10.1016/j.bonr.2016.10.002.
Hikata, T., Hasegawa, T., Horiuchi, K., Fujita, N., Iwanami, A., Watanabe, K., Ishii, K., Nakamura, M., Amizuka, N., & Matsumoto, M. (2016). Histomorphometric analysis of minimodeling in the vertebrae in postmenopausal patients treated with anti-osteoporotic agents. Bone reports, 5286-291. https://doi.org/10.1016/j.bonr.2016.10.002
Hikata, Tomohiro, et al. "Histomorphometric analysis of minimodeling in the vertebrae in postmenopausal patients treated with anti-osteoporotic agents." Bone reports vol. 5 (2016): 286-291. doi: https://doi.org/10.1016/j.bonr.2016.10.002
Hikata T, Hasegawa T, Horiuchi K, Fujita N, Iwanami A, Watanabe K, Ishii K, Nakamura M, Amizuka N, Matsumoto M. Histomorphometric analysis of minimodeling in the vertebrae in postmenopausal patients treated with anti-osteoporotic agents. Bone Rep. 2016 Oct 13;5:286-291. doi: 10.1016/j.bonr.2016.10.002. eCollection 2016 Dec. PMID: 28580398; PMCID: PMC5440780.
Copy Download .nbib Format: NLM
Gross hematuria and bladder tumor in a patient with advanced thyroid papillary carcinoma.

Case reports in endocrinology

Ando T, Matsuo Y, Ikeoka T, Oba K, Miyata Y, Sakai H, Abe K, Kawakami A.
PMID: 23762664
Case Rep Endocrinol. 2013;2013:585781. doi: 10.1155/2013/585781. Epub 2013 May 13.

We present a 73-year-old female with advanced thyroid papillary carcinoma who complained of gross hematuria. We found a bladder tumor and considered it the cause of her symptom. Cystoscopic findings of the tumor were unusual, with peri-tumor vessel formation....

Cite
Ando T, Matsuo Y, Ikeoka T, et al. Gross hematuria and bladder tumor in a patient with advanced thyroid papillary carcinoma. Case Rep Endocrinol. 2013;2013:585781doi: 10.1155/2013/585781.
Ando, T., Matsuo, Y., Ikeoka, T., Oba, K., Miyata, Y., Sakai, H., Abe, K., & Kawakami, A. (2013). Gross hematuria and bladder tumor in a patient with advanced thyroid papillary carcinoma. Case reports in endocrinology, 2013585781. https://doi.org/10.1155/2013/585781
Ando, Takao, et al. "Gross hematuria and bladder tumor in a patient with advanced thyroid papillary carcinoma." Case reports in endocrinology vol. 2013 (2013): 585781. doi: https://doi.org/10.1155/2013/585781
Ando T, Matsuo Y, Ikeoka T, Oba K, Miyata Y, Sakai H, Abe K, Kawakami A. Gross hematuria and bladder tumor in a patient with advanced thyroid papillary carcinoma. Case Rep Endocrinol. 2013;2013:585781. doi: 10.1155/2013/585781. Epub 2013 May 13. PMID: 23762664; PMCID: PMC3666427.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1035 entries